Gri bio showcases gri-0621's potential to reduce inflammation, type 1 cytokines and reduce hepatic fibrosis in idiopathic pulmonary fibrosis (ipf)

Workshop, poster and oral presentation of data given as part of the 8 th annual antifibrotic drug development (afdd) summit
GRI Ratings Summary
GRI Quant Ranking